Antibiotics instead of surgery for appendicitis; Epilepsy drug settlement:...
In today’s health headlines: A study finds antibiotics may be a safe treatment for appendicitis for some children, an Ohio measles outbreak forces kids to stay home, and a settlement in a epilepsy drug...
View ArticleThe Pervasiveness of Health Care Corruption as Shown by Another Roundup of...
Yves here. This post is important, not simply for chronicling health care corruption, but also in demonstrating how, just as in financial services, the individuals responsible are not targeted for...
View ArticlePfizer to pay $325 mln in Neurontin settlement
Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the...
View ArticlePfizer to pay $325 million in Neurontin settlement
Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the...
View ArticlePfizer to shell out $325M to settle Neurontin off-label lawsuit
(Reuters) - Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement...
View ArticlePfizer Agrees to $325 Million Neurontin Marketing Accord
Pfizer Inc. (PFE) agreed to pay $325 million to settle a lawsuit brought by health-care benefit providers who claimed the drugmaker marketed the epilepsy drug Neurontin for unapproved uses.
View ArticlePfizer agrees to pay $325M to settle Neurontin suit
Pfizer Inc. agreed to pay $325 million to settle a lawsuit brought by health-care benefit providers who claimed the drugmaker marketed the epilepsy drug Neurontin for unapproved uses. The... To view...
View ArticlePfizer To Pay $325M in settlement
Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the...
View ArticleA few facts before passage of another anti-abortion bill
HB 1374, to ban the common, or off-label, dosage o f RU-486, a pill used to induce a miscarriage in the first eight weeks of pregnancy, is on the agenda of a Senate committee today and likely headed to...
View Article
